Key result
Elective mitral valve repair for chronic ischemic mitral regurgitation resulted in 3.1% hospital mortality, with 111 of 121 patients having trivial or no residual regurgitation at 19.65 months.
Cohort (n=127)
Mitral valve repair for chronic ischemic mitral regurgitation is a reproducible technique with satisfactory early and mid-term outcomes and low rates of residual regurgitation.
Supports repair feasibility with low mortality in chronic ischemic MR; leaves open randomized confirmation of outcomes.
Mitral regurgitation is a frequent complication of ischemic heart disease. A retrospective study was performed on 127 patients with significant ischemic mitral regurgitation (regurgitant jet area > or =6.0 cm2 and/or vena contracta width > or =0.70 cm) who underwent elective mitral valve repair between January 2001 and October 2007. Concomitant myocardial revascularization was carried out in all except one patient, and left ventricular restoration in 8. All patients had ring annuloplasty, with release of posterior mitral leaflet tethering in 21, leaflet resection in 7, chordal transfer in 3, and chordal shortening in 2. There were 4 (3.1%) hospital deaths. Two patients underwent successful mitral valve replacement for repair failure in the immediate postoperative period, and one had an unsuccessful valve replacement at 3 months. During a mean follow-up of 19.65 +/- 13.21 months in 121 patients, 111 had trivial or no residual regurgitation, and 10 had mild regurgitation. Mitral valve repair for chronic ischemic mitral regurgitation is a reproducible technique with satisfactory early and mid-term outcomes and freedom from valve-related complications.
No takes yet. Share an insight, caveat, or question.
Sajja et al. (2009) conducted a cohort in Chronic ischemic mitral regurgitation (n=127). Elective mitral valve repair was evaluated on Hospital deaths. Elective mitral valve repair for chronic ischemic mitral regurgitation resulted in 3.1% hospital mortality, with 111 of 121 patients having trivial or no residual regurgitation at 19.65 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Mitral valve interventionMore from Asian Cardiovascular and Thoracic Annals